Jha Ajay K, Sunder Ashok, Kumari Shweta, Dubey Keertee
Department of Medicine, Tata Main Hospital, Jamshedpur, Jharkhand, India.
Department of Obst. and Gynaecology, Medica Superspeciality Hospital, Jamshedpur, Jharkhand, India.
J Family Med Prim Care. 2020 Oct 30;9(10):5372-5374. doi: 10.4103/jfmpc.jfmpc_644_20. eCollection 2020 Oct.
Primary peritoneal carcinoma (PPC) was first described in 1959 by Swerdlow. It is a rare malignant tumor of the peritoneal cavity. Clinically and histologically it is similar to advanced-stage serous ovarian carcinoma that develops from the peritoneum lining the pelvis and abdomen and is characterized by abdominal carcinomatosis, uninvolved or minimally involved ovaries, and no identifiable primary tumor. This cancer spreads widely inside the peritoneal cavity and mostly involves the omentum. There is some thought that the peritoneal cells that give rise to peritoneal cancer may actually be leftover ovarian cells that remained in the abdomen during development. It is almost exclusively found in women. Clinical features include abdominal swelling, constipation, gastrointestinal disorders, nausea, vomiting, anorexia, and weight loss.
原发性腹膜癌（PPC）于1959年由斯韦德洛首次描述。它是一种罕见的腹膜腔恶性肿瘤。在临床和组织学上，它与晚期浆液性卵巢癌相似，后者起源于盆腔和腹部的腹膜，其特征为腹部癌转移、卵巢未受累或仅有轻微受累，且无明确的原发性肿瘤。这种癌症在腹膜腔内广泛扩散，主要累及大网膜。有人认为，引发腹膜癌的腹膜细胞实际上可能是发育过程中留在腹部的残留卵巢细胞。它几乎只在女性中发现。临床特征包括腹部肿胀、便秘、胃肠道紊乱、恶心、呕吐、厌食和体重减轻。
